Free-cash-flow margin moved 928 bp lower
Free-cash-flow margin changed -928 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
32.63%→23.35%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →RBLX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash-flow margin moved 1504 bp lower
Operating cash-flow margin changed -1504 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
40.17%→25.13%2 prior comparisons
SBC / revenue moved 215 bp lower
SBC / revenue changed -215 basis points from the comparable as-filed period.
21.10%→18.96%2 prior comparisons
Capital expenditure decreased 72.7%
Capital expenditure changed -72.7% from the comparable as-filed period.
$102.6M→$28.0M2 prior comparisons
Total assets increased 16.9%
Total assets changed +16.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$8.6B→$10.0B4 prior comparisons
Short-term borrowings decreased 100.0%
Short-term borrowings changed -100.0% from the comparable as-filed period.
$14.7M→$01 prior comparisons
Receivables / revenue moved 1503 bp lower
Receivables / revenue changed -1503 basis points from the comparable as-filed period.
46.65%→31.62%2 prior comparisons
Cash & equivalents increased 7.5%
Cash & equivalents changed +7.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.0B→$1.1B4 prior comparisons
Current assets increased 8.8%
Current assets changed +8.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$4.4B→$4.7B4 prior comparisons
Net income increased 11.2%
Net income changed +11.2% from the comparable as-filed period.
-$255.6M→-$227.0M2 prior comparisons
Research & development increased 9.2%
Research & development changed +9.2% from the comparable as-filed period.
$398.3M→$435.0M2 prior comparisons
R&D / revenue moved 162 bp lower
R&D / revenue changed -162 basis points from the comparable as-filed period.
29.29%→27.67%2 prior comparisons
Noncurrent long-term debt increased 1.6%
Noncurrent long-term debt changed +1.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$992.7M→$1.0B4 prior comparisons
Operating income increased 4.6%
Operating income changed +4.6% from the comparable as-filed period.
-$296.5M→-$283.0M2 prior comparisons
Cost of revenue increased 7.3%
Cost of revenue changed +7.3% from the comparable as-filed period.
$296.5M→$318.0M2 prior comparisons
Stock-based compensation increased 3.9%
Stock-based compensation changed +3.9% from the comparable as-filed period.
$286.9M→$298.0M2 prior comparisons
Total assets increased 24.2%
Total assets changed +24.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$7.8B→$9.7B4 prior comparisons
Noncurrent long-term debt increased 1.7%
Noncurrent long-term debt changed +1.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$992.4M→$1.0B4 prior comparisons
Free-cash-flow margin moved 380 bp higher
Free-cash-flow margin changed +380 basis points from the comparable as-filed period.
16.35%→20.15%2 prior comparisons
Operating cash-flow margin moved 321 bp higher
Operating cash-flow margin changed +321 basis points from the comparable as-filed period.
18.44%→21.65%2 prior comparisons
R&D / revenue moved 703 bp lower
R&D / revenue changed -703 basis points from the comparable as-filed period.
35.63%→28.59%2 prior comparisons
Short-term borrowings decreased 100.0%
Short-term borrowings changed -100.0% from the comparable as-filed period.
$14.7M→$00 prior comparisons
Cost of revenue increased 23.7%
Cost of revenue changed +23.7% from the comparable as-filed period.
$236.1M→$292.0M2 prior comparisons
Current assets increased 14.9%
Current assets changed +14.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.9B→$4.5B4 prior comparisons
Receivables / revenue moved 1463 bp lower
Receivables / revenue changed -1463 basis points from the comparable as-filed period.
48.53%→33.90%2 prior comparisons
Research & development increased 9.1%
Research & development changed +9.1% from the comparable as-filed period.
$385.0M→$420.0M2 prior comparisons
Trade receivables decreased 5.1%
Trade receivables changed -5.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$524.5M→$498.0M4 prior comparisons
Capex / revenue moved 59 bp lower
Capex / revenue changed -59 basis points from the comparable as-filed period.
2.09%→1.50%2 prior comparisons
Cash & equivalents decreased 0.4%
Cash & equivalents changed -0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$994.6M→$991.0M4 prior comparisons
Capital expenditure decreased 2.7%
Capital expenditure changed -2.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$22.6M→$22.0M3 prior comparisons
Stock-based compensation decreased 1.0%
Stock-based compensation changed -1.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$284.8M→$282.0M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.